Janssen J P, Mulder J J, Wagenaar S S, Elbers H R, van den Bosch J M
Department of Pulmonary Diseases, St. Antonius Hospital, Nieuwegein, The Netherlands.
Ann Thorac Surg. 1994 Oct;58(4):1151-5. doi: 10.1016/0003-4975(94)90476-6.
Primary pulmonary sarcoma is an extremely rare tumor. In more than 30 years, only 22 patients with PPS were seen in our hospital; 18 patients (82%) underwent operation. Radical resection is the only curative treatment in patients with primary pulmonary sarcoma. All 4 patients (18%) who did not undergo operation died within 17 months. All 7 patients (32%) in whom no radical resection could be performed died between 10 months and 16 years after operation. Total resection of the tumor could be performed in 11 patients (50%). Of these, 7 are still alive (64%), and 1 patient died of an unrelated cause after 25 years (mean follow-up, 13.5 years). Histologic diagnosis in these patients was leiomyosarcoma in 4, malignant schwannoma in 2, and fibrosarcoma and undifferentiated sarcoma in 1 each. Median survival for all patients was 24 months. Actuarial 5-year survival was 44% for all patients. Small tumor diameter and low-grade malignancy are statistically significant favorable prognostic factors. No patient with grade 1 tumor died; the median survival was 60 months for grade 2 sarcomas, and 17 months for grade 3 sarcomas. No patient with a completely resected small primary pulmonary sarcoma had recurrence or metastasis.
原发性肺肉瘤是一种极其罕见的肿瘤。30多年来,我院仅收治22例原发性肺肉瘤患者;18例(82%)接受了手术。根治性切除是原发性肺肉瘤患者唯一的治愈性治疗方法。未接受手术的4例患者(18%)均在17个月内死亡。无法进行根治性切除的7例患者(32%)在术后10个月至16年之间死亡。11例患者(50%)实现了肿瘤全切。其中,7例仍存活(64%),1例患者在25年后死于非相关原因(平均随访13.5年)。这些患者的组织学诊断为平滑肌肉瘤4例、恶性神经鞘瘤2例、纤维肉瘤和未分化肉瘤各1例。所有患者的中位生存期为24个月。所有患者的5年精算生存率为44%。肿瘤直径小和低级别恶性在统计学上是显著的有利预后因素。1级肿瘤患者无死亡;2级肉瘤的中位生存期为60个月,3级肉瘤为17个月。原发性肺小肉瘤完全切除的患者无复发或转移。